Asymmetric Synthesis of the <i>cis</i>-1,2-Diaryltetralin Vepdegestrant Core via an Enantioselective Intramolecular Corey-Chaykovsky Epoxidation
An asymmetric synthesis of cis-1,2-diaryltetralin (2), a key chiral intermediate in the synthesis of Vepdegestrant (1), an orally available PROTAC being evaluated for the treatment of ER+/HER2- breast cancer, is reported. Chirality is initially introduced via a catalytic enantioselective intramolecular Corey-Chaykovsky epoxidation utilizing isothiocineole, a chiral sulfide. Although several asymmetric intermolecular epoxidations using chiral sulfides have been reported, our approach represents a unique intramolecular variant. The subsequent introduction of the cis-1,2-diaryl motif is achieved via diastereoselective hydrogenation.
Authors
- David J. Bernhardson (ORCID: https://orcid.org/0000-0002-4052-8294)
- Robert A. Singer (ORCID: https://orcid.org/0000-0001-9730-1261)
- Liam S. Sharninghausen (ORCID: https://orcid.org/0000-0002-2249-1010)
- Zebediah C. Girvin (ORCID: https://orcid.org/0000-0001-5338-1319)
- Yexenia Nieves‐Quinones
- J. Christopher McWilliams (ORCID: https://orcid.org/0000-0002-4764-735X)
- Zheng Wang (ORCID: https://orcid.org/0000-0002-7560-2618)
- Sarai Lara-Boykin
Institutions
- Pfizer (United States) (US)
Publication Details
- Journal
- Organic Process Research & Development
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1021/acs.oprd.4c00379
- Citations
- 10
- Primary Topic
- Asymmetric Synthesis and Catalysis
- Type
- article
- Field-Weighted Citation Impact
- 2.50